Interaction of cationic peptides with bacterial membranes.
Fidai
S
S
Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.
Farmer
S W
SW
Hancock
R E
RE
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism* / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides; D001419:Bacteria / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism*; D002463:Cell Membrane Permeability / Q000187:drug effects; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D003619:Dansyl Compounds / Q000378:metabolism; D004357:Drug Synergism; D005347:Fibroblasts; D005456:Fluorescent Dyes / Q000378:metabolism; D008051:Lipid Bilayers / Q000378:metabolism; D008070:Lipopolysaccharides / Q000378:metabolism / Q000494:pharmacology; D008264:Macrophages; D051379:Mice; D009113:Muramidase / Q000378:metabolism; D011112:Polymyxin B / Q000378:metabolism; D011506:Proteins / Q000378:metabolism* / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D003619:Dansyl Compounds; D005456:Fluorescent Dyes; D008051:Lipid Bilayers; D008070:Lipopolysaccharides; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; C005444:N-phenyl-1-naphthylamine; D015057:1-Naphthylamine; D009113:Muramidase; D011112:Polymyxin B